Current location:style >>
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
style3441People have gathered around
IntroductionWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the b ...
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Tags:
Reprint:Friends are welcome to share on the Internet, but please indicate the source of the article when reprinting it.“Universal Unfoldings news portal”。http://malta.downmusic.org/content-84d599395.html
Related articles
Burglar hurled stolen mobile phones at police from the top of 60ft high roof during nine
styleA burglar hurled stolen mobile phones at police officers from the top of a roof during a nine-hour s ...
【style】
Read moreChina cuts 88 bln yuan in logistics costs in 2017
styleChina reduced logistics costs by more than 88 billion yuan (13.4 billion U.S. dollars) in 2017, the ...
【style】
Read moreReactor pressure vessel of Hualong One nuclear project installed in China's Fujian
stylePhoto taken on Jan. 28, 2018 shows the installation site of reactor pressure vessel (RPV) of the No. ...
【style】
Read more
Popular articles
Latest articles
LINKS
- Upcoming Met Gala exhibit aims to be a multi
- Displaced Lebanese long for home as Hezbollah
- China's outbound tourism sees robust recovery during 'golden week' holiday
- China: An active participant in promoting human rights within the framework of global governance
- The 39th Harbin International Ice and Snow Festival is around the corner
- World awaits Chinese tourists' return
- Did Dwayne Johnson say he regretted supporting Biden in 2020? — Radio Free Asia
- Ukrainian president, senior NATO official meet on support for Kiev
- An ocean of opportunity
- I visited a £400 wellness retreat in Wales to try the ancient Japanese art of forest bathing